Indeed, the retrospective analysis indicated a high CALR mutation burden between initial CML diagnosis and secondary Ph− MPN diagnosis, regardless of the BCR-ABL1 transcript level. This evidence concerns the gene ABL1 and myeloproliferative neoplasm.